Ben Atkins
Nessuna posizione attualmente
Profilo
Ben Atkins worked as the VP of Communications & Investor Relations at Opiant Pharmaceuticals, Inc..
Mr. Atkins attended King's College London for his undergraduate degree.
Precedenti posizioni note di Ben Atkins
| Società | Posizione | Fine |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | 02/03/2023 |
Formazione di Ben Atkins
| King's College London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Società collegate
| Aziende private | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Borsa valori
- Insiders
- Ben Atkins
